ER mitochondria calcium cycle (ERMCC) dysregulation in motor neurons of ALS mouse model as target for new therapeutic strategies:
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Abschlussarbeit Buch |
Sprache: | English |
Veröffentlicht: |
Jena
June 2017
|
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis Inhaltsverzeichnis |
Beschreibung: | VIII, 75, xvii Seiten Illustrationen 29 cm |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV045218809 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | t | ||
008 | 181004s2017 gw a||| m||| 00||| eng d | ||
015 | |a 18,H05 |2 dnb | ||
016 | 7 | |a 1155763106 |2 DE-101 | |
020 | |c Broschur | ||
035 | |a (OCoLC)1136430504 | ||
035 | |a (DE-599)DNB1155763106 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
044 | |a gw |c XA-DE | ||
049 | |a DE-355 | ||
084 | |a 610 |2 sdnb | ||
100 | 1 | |a Tadić, Vedrana |d 1985- |e Verfasser |0 (DE-588)1155271432 |4 aut | |
245 | 1 | 0 | |a ER mitochondria calcium cycle (ERMCC) dysregulation in motor neurons of ALS mouse model as target for new therapeutic strategies |c by M.Sc. Vedrana Tadić |
264 | 1 | |a Jena |c June 2017 | |
300 | |a VIII, 75, xvii Seiten |b Illustrationen |c 29 cm | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
502 | |b Dissertation |c Friedrich Schiller University of Jena |d 2017 | ||
655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
856 | 4 | 2 | |m B:DE-101 |q application/pdf |u http://d-nb.info/1155763106/04 |3 Inhaltsverzeichnis |
856 | 4 | 2 | |m DNB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030607454&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-030607454 |
Datensatz im Suchindex
_version_ | 1804178936064638976 |
---|---|
adam_text | TABLE OF CONTENTS
TABLE OF
CONTENTS................................................................................................
I
LIST OF
ABBREVIATIONS........................................................................................
ILL
SUMMARY...................................................................................................................
V
ZUSAMMENFASSUNG.............................................................................................VII
1
INTRODUCTION................................................................................................1
1.1 ALS
PATHOLOGY..................................................................................................
1
1.2 DIAGNOSIS AND
THERAPY.....................................................................................3
1.3 MOTOR NEURON
INJURY.........................................................................................
5
1.3.1 INTRACELLULAR CA2+ HOMEOSTASIS AND ORGANELLE DYSFUNCTION IN ALS
.......
5
1.3.2 MITOCHONDRIAL IMPAIRMENT AND OXIDATIVE STRESS
....................................
7
1.3.3 ER STRESS AND DEREGULATION OF SIG1 R AT THE MAMS
............................
8
1.3.4 DNA DAMAGE IN ALS MOTOR NEURONS
...................................................
9
2 AIMS OF THE
STUDY....................................................................................
10
3 MATERIALS AND
METHODS........................................................................
12
3.1
ANIMALS............................................................................................................12
3.2 PRIMARY MOTOR NEURON-ENRICHED
CULTURES....................................................13
3.2.1 PREPARATION OF THE PLATES FOR SEEDING OF MOTOR NEURONS
....................
14
3.2.2 PREPARATION OF THE PRIMARY MOTOR NEURON-ENRICHED CULTURES
.............
14
3.2.3 GENOTYPING OF MICE
EMBRYOS.............................................................15
3.3 STAINING AND QUANTIFICATION
PROTOCOLS.........................................................15
3.3.1 STAINING AND VISUALIZATION OF MITOCHONDRIAL NETWORK
.........................
15
3.3.2 IMMUNOCYTOCHEMISTRY IN PRIMARY MOTOR NEURONS AND ASTROCYTES
......
17
3.3.3 QUANTIFICATION OF IMMUNOCYTOCHEMISTRY
SIGNAL.................................
.
17
3.3.4 SURVIVAL ASSAY FOLLOWING PHARMACOLOGICAL MANIPULATION OF ERMCC. 18
3.3.5 INVESTIGATION OF MRNA
LEVELS.............................................................19
3.4 CALCIUM
IMAGING.............................................................................................19
3.4.1 ANALYSIS OF CALCIUM IMAGING DATA
.....................................................
21
3.5
STATISTICS.........................................................................................................
21
3.6 MEDIA, BUFFERS AND LABORATORY CONSUMABLES
..............................................
23
3.6.1 MEDIA AND SUBSTANCES FOR MOTOR NEURON-ENRICHED CULTURES
..............
23
3.6.2 PRIMERS AND PROGRAMS FOR PCR AND QPCR
.......................................
25
3.6.3 IMMUNOCYTOCHEMISTRY PROTOCOLS FOR MOTOR NEURONS AND ASTROCYTES..26
3.6.4 SUBSTANCES USED FOR CALCIUM IMAGING AND VIABILITY ASSAY
................
28
3.6.5
SOFTWARE............................................................................................
28
4
RESULTS........................................................................................................
29
4.1 G93AHSOD1 ALTERS MITOCHONDRIAL STRUCTURE AND FUNCTION
...............................
29
4.1.1 MITOCHONDRIA ARE FRAGMENTED IN G93AHSOD1 MOTOR NEURONS
..............
29
4.1.2 MOTOR NEURON DEPENDENCY ON MITOCHONDRIAL CA2+ BUFFERING
..............
32
4.1.3 MITOCHONDRIA AND ER BUFFER GREAT PORTION OF CYTOSOLIC CA2+
..............
34
4.1.4 MCU IS OVEREXPRESSED IN G93AHSOD1 MOTOR NEURONS
........................
37
4.1.5 G93AHSOD1 ALTERS SPONTANEOUS CYTOSOLIC CA2+ ACTIVITY
......................
40
4.1.6 KN-62 PROTECTED G93AHSOD1 MOTOR NEURONS AGAINST KAINATE
............
42
4.2 ER-MITOCHONDRIA BRIDGE PROTEIN, SIG1R, MODULATES CYTOSOLIC CA2+
HOMEOSTASIS............................................................................................................
45
4.2.1 EXPRESSION OF SIG1 R WAS INCREASED IN G93AHSOD1 MOTOR NEURONS
...45
4.2.2 SIG1R AGONISTS DIFFERENTLY AFFECT SIG1 R EXPRESSION IN G93AHSOD1
AND
NONTG MOTOR NEURONS
.......................................................................................
46
4.2.3 SELECTIVE VULNERABILITY OF MOTOR
NEURONS...........................................48
4.2.4 BRADYKININ-SENSITIVE INTRACELLULAR CA2+ STORES ARE REDUCED IN
G93AHSOD1 SPINAL NEURONS
..............................................................................
49
4.2.5 PRE-084 DOES NOT ALTER BRADYKININ-SENSITIVE CA2+ STORES IN
G93AHSOD1
SPINAL
NEURONS.................................................................................................50
4.2.6 SA4503 RESCUES BRADYKININ-INDUCED CA2+ RELEASE IN G93AHSOD1
SPINAL
NEURONS.................................................................................................51
4.2.7 PRE-084 DOES NOT AFFECT CYTOSOLIC CA2+ CLEARANCE FOLLOWING AMPAR
STIMULATION.......................................................................................................54
4.2.8 SA4503 ACCELERATES CYTOSOLIC CA2+ CLEARANCE FOLLOWING AMPAR
STIMULATION.......................................................................................................55
4.2.9 ER CA2+ STORAGE IS INCREASED IN G93AHSOD1 SPINAL NEURONS
.............
57
4.3 G93AHSOD1 DOES NOT INCREASE NUCLEAR DMA DAMAGE
..................................
59
5
DISCUSSION..................................................................................................62
5.1 MITOCHONDRIA IN ALS: A TRIGGER AND A TARGET
...............................................
62
5.1.1 MITOCHONDRIAL DYNAMICS ARE ALTERED IN G93AHSOD1 MOTOR NEURONS
...62
5.1.2 MOTOR NEURONS DEPEND ON MITOCHONDRIAL CA2+ BUFFERING
...................
63
5.1.3 MCU AS A TARGET AGAINST EXCITOTOXICITY
.............................................
64
5.2 SIG1R: A TOOL FOR ERMCC STABILIZATION IN ALS
............................................
66
5.2.1 SIG1R IS DEREGULATED IN G93AHSOD1 MOTOR NEURONS
..........................
66
5.2.2 SIG1R AGONISTS DO NOT RESCUE AGAINST KAINATE-INDUCED
EXCITOTOXICITY
67
5.2.3 SIG1 R MODULATES INTER-ORGANELLE CA2+ EXCHANGE
.............................
67
5.3 G93AHSOD1 DOES NOT INCREASE NUCLEAR DNA DAMAGE
..................................
69
5.4 ORGANELLE INTERPLAY IS DISTURBED IN THE PRESENCE OF G93AHSOD1
................
70
5.5 STRENGTHS AND LIMITATIONS OF THE STUDY
.......................................................
74
6 CONCLUSION AND OUTLOOK
....................................................................
75
7
LITERATURE.....................................................................................................I
8
APPENDIX.....................................................................................................
XII
8.1 LIST OF
FIGURES.................................................................................................XII
8.2 LIST OF
TABLES.................................................................................................XIII
8.3
ACKNOWLEDGEMENTS......................................................................................XIV
8.4
PUBLICATIONS..................................................................................................XVI
8.4.1 ORIGINAL
PUBLICATIONS.........................................................................XVI
8.4.2
REVIEWS............................................................................................
XVI
8.4.3 POSTER
PRESENTATIONS.......................................................................
XVII
8.4.4
TALKS................................................................................................
XVII
8.5 EHRENWOERTLICHE ERKLAERUNG
.........................................................................
XVIII
|
any_adam_object | 1 |
author | Tadić, Vedrana 1985- |
author_GND | (DE-588)1155271432 |
author_facet | Tadić, Vedrana 1985- |
author_role | aut |
author_sort | Tadić, Vedrana 1985- |
author_variant | v t vt |
building | Verbundindex |
bvnumber | BV045218809 |
ctrlnum | (OCoLC)1136430504 (DE-599)DNB1155763106 |
discipline | Medizin |
format | Thesis Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01413nam a2200349 c 4500</leader><controlfield tag="001">BV045218809</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">181004s2017 gw a||| m||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">18,H05</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1155763106</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="c">Broschur</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1136430504</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1155763106</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Tadić, Vedrana</subfield><subfield code="d">1985-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1155271432</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">ER mitochondria calcium cycle (ERMCC) dysregulation in motor neurons of ALS mouse model as target for new therapeutic strategies</subfield><subfield code="c">by M.Sc. Vedrana Tadić</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Jena</subfield><subfield code="c">June 2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VIII, 75, xvii Seiten</subfield><subfield code="b">Illustrationen</subfield><subfield code="c">29 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="b">Dissertation</subfield><subfield code="c">Friedrich Schiller University of Jena</subfield><subfield code="d">2017</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">B:DE-101</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://d-nb.info/1155763106/04</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030607454&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030607454</subfield></datafield></record></collection> |
genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
genre_facet | Hochschulschrift |
id | DE-604.BV045218809 |
illustrated | Illustrated |
indexdate | 2024-07-10T08:11:53Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030607454 |
oclc_num | 1136430504 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | VIII, 75, xvii Seiten Illustrationen 29 cm |
publishDate | 2017 |
publishDateSearch | 2017 |
publishDateSort | 2017 |
record_format | marc |
spelling | Tadić, Vedrana 1985- Verfasser (DE-588)1155271432 aut ER mitochondria calcium cycle (ERMCC) dysregulation in motor neurons of ALS mouse model as target for new therapeutic strategies by M.Sc. Vedrana Tadić Jena June 2017 VIII, 75, xvii Seiten Illustrationen 29 cm txt rdacontent n rdamedia nc rdacarrier Dissertation Friedrich Schiller University of Jena 2017 (DE-588)4113937-9 Hochschulschrift gnd-content B:DE-101 application/pdf http://d-nb.info/1155763106/04 Inhaltsverzeichnis DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030607454&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Tadić, Vedrana 1985- ER mitochondria calcium cycle (ERMCC) dysregulation in motor neurons of ALS mouse model as target for new therapeutic strategies |
subject_GND | (DE-588)4113937-9 |
title | ER mitochondria calcium cycle (ERMCC) dysregulation in motor neurons of ALS mouse model as target for new therapeutic strategies |
title_auth | ER mitochondria calcium cycle (ERMCC) dysregulation in motor neurons of ALS mouse model as target for new therapeutic strategies |
title_exact_search | ER mitochondria calcium cycle (ERMCC) dysregulation in motor neurons of ALS mouse model as target for new therapeutic strategies |
title_full | ER mitochondria calcium cycle (ERMCC) dysregulation in motor neurons of ALS mouse model as target for new therapeutic strategies by M.Sc. Vedrana Tadić |
title_fullStr | ER mitochondria calcium cycle (ERMCC) dysregulation in motor neurons of ALS mouse model as target for new therapeutic strategies by M.Sc. Vedrana Tadić |
title_full_unstemmed | ER mitochondria calcium cycle (ERMCC) dysregulation in motor neurons of ALS mouse model as target for new therapeutic strategies by M.Sc. Vedrana Tadić |
title_short | ER mitochondria calcium cycle (ERMCC) dysregulation in motor neurons of ALS mouse model as target for new therapeutic strategies |
title_sort | er mitochondria calcium cycle ermcc dysregulation in motor neurons of als mouse model as target for new therapeutic strategies |
topic_facet | Hochschulschrift |
url | http://d-nb.info/1155763106/04 http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030607454&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT tadicvedrana ermitochondriacalciumcycleermccdysregulationinmotorneuronsofalsmousemodelastargetfornewtherapeuticstrategies |
Es ist kein Print-Exemplar vorhanden.
Inhaltsverzeichnis